search
Back to results

A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. (TIGER)

Primary Purpose

Acne Vulgaris

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Acne Mask
2.5% Benzoyl Peroxide Treatment
Sponsored by
Johnson & Johnson Consumer and Personal Products Worldwide
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acne Vulgaris focused on measuring Acne

Eligibility Criteria

12 Years - 40 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Has mild to moderate acne
  • Has 10 - 100 pimples, 10 - 50 inflamed red pimples, up to 2 raised bumps and no cysts
  • In general good health
  • Must avoid excessive sun exposure and any light treatments or any professional or aesthetic spa-like procedures
  • Must not be pregnant, nursing or intend to become pregnant during the study
  • Must agree to practice a medically acceptable form of birth control.
  • Must be able to read, speak, write and understand English

Exclusion Criteria:

  • Allergies or sensitivities to product ingredients or to light
  • Has severe acne or pre-existing dermatological facial condition
  • Has an uncontrolled disease or immune deficient disorder
  • Is pregnant, breast-feeding or intending to become pregnant
  • Has been taking prescription drug medication for acne or antibiotics for the past 6 months

Sites / Locations

  • Academic Dermatology Associates
  • Thomas J. Stephens and Associates, Inc.

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Acne Mask

2.5% Benzoyl Peroxide Treatment

Arm Description

The light therapy acne device is applied to the face once in the evening for a duration of 10 minutes. The cleanser is used twice daily, once in the morning and once in the evening. Other Names: Cleanser is marketed while the device is not marketed

Cleanser and 2.5% Benzoyl Peroxide Treatment Both the cleanser and the 2.5% Benzoyl Peroxide Treatment are applied twice daily, once in the morning and once in the evening. Other names: Both products are marketed

Outcomes

Primary Outcome Measures

Percent Change of Global Face Total Acne Lesion Count From Baseline

Secondary Outcome Measures

Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 1
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 2
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 4
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 8
Acne Lesion Counts Total Global Face - Baseline
Acne Lesion Count Total Global Face at Baseline
Acne Lesion Counts Total Global Face - Week 1
Acne Lesion Count Total Global Face Week 1
Acne Lesion Counts Total Global Face - Week 2
Acne Lesion Count Total Global Face Week 2
Acne Lesion Counts Total Global Face - Week 4
Acne Lesion Count Total Global Face Week 4
Acne Lesion Counts Total Global Face - Week 8
Acne Lesion Count Total Global Face Week 8
Acne Lesion Counts Total Global Face - Week 12
Acne Lesion Count Total Global Face Week 12
Investigator Global Acne Assessment - Baseline
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Investigator Global Acne Assessment - Week 1
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Investigator Global Acne Assessment - Week 2
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Investigator Global Acne Assessment - Week 4
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Investigator Global Acne Assessment - Week 8
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Investigator Global Acne Assessment - Week 12
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.

Full Information

First Posted
February 26, 2016
Last Updated
December 27, 2017
Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
search

1. Study Identification

Unique Protocol Identification Number
NCT02698436
Brief Title
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.
Acronym
TIGER
Official Title
A Multi-Center, Evaluator Blinded, Randomized Clinical Study to Evaluate the Efficacy and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne Vulgaris
Study Type
Interventional

2. Study Status

Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
March 31, 2016 (Actual)
Primary Completion Date
August 31, 2016 (Actual)
Study Completion Date
August 31, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will compare two different acne treatments for the treatment of acne. Half of the participants will receive two marketed acne products (cleanser and leave-on topical treatment), while the other half of the participants will receive a marketed cleanser and a light-therapy device.
Detailed Description
Acne is a common chronic skin disease involving blockage and/or inflammation of the hair follicles and their accompanying sebaceous gland. Benzoyl peroxide (BPO) is one of the most effective and well-studied over-the-counter (OTC) acne therapies, is generally regarded as safe and effective and is considered as a first-line treatment for acne. Topical BPO monotherapy products for at-home acne treatment have been available for OTC use for more than 30 years and studies have indicated that a low dose of BPO may be an effective approach for treating acne using an OTC product when applied consistently to larger areas of the face due primarily to its effects against acne-causing bacteria. BPO has anti-inflammatory and keratolytic properties, but is thought to act primarily to control P. acnes by releasing reactive oxygen species that are toxic to the bacteria. The most common side effect of topical BPO treatment is skin irritation, which can include erythema, burning, and peeling. As an alternative to topical OTC standard of care therapies, research has also shown the benefits of red and blue light therapy in the treatment of mild to moderate acne, with red and blue light shown to target the acne-causing bacteria and have an effect on inflammation reduction. Light-based therapies have been successfully used to treat dermatological conditions since the early 1900's, with various parts of the electromagnetic spectrum (i.e. UV, visible, near-Infrared, etc.) demonstrating different benefits. Light-emitting diodes (LEDs) offer delivery of light to the skin in a gentler manner as compared to light delivered by lasers primarily due to the lower energy output. It has been reported that LEDs do not deliver enough power to damage tissues and do not have the same risk of accidental eye damage that lasers do. Visible-LED light therapy has been deemed a non-significant risk by the Food and Drug Administration and has been approved for use in humans. This study will look to compare the acne clearing efficacy and tolerance of two different acne treatments: a currently marketed 2.5% BPO full-face topical OTC treatment, and an Investigational red and blue light acne light therapy mask, to determine if the acne resolution efficacy of the Investigational mask is as effective as a current OTC standard of care for at-home treatment of mild to moderate acne.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acne Vulgaris
Keywords
Acne

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
103 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Acne Mask
Arm Type
Experimental
Arm Description
The light therapy acne device is applied to the face once in the evening for a duration of 10 minutes. The cleanser is used twice daily, once in the morning and once in the evening. Other Names: Cleanser is marketed while the device is not marketed
Arm Title
2.5% Benzoyl Peroxide Treatment
Arm Type
Active Comparator
Arm Description
Cleanser and 2.5% Benzoyl Peroxide Treatment Both the cleanser and the 2.5% Benzoyl Peroxide Treatment are applied twice daily, once in the morning and once in the evening. Other names: Both products are marketed
Intervention Type
Device
Intervention Name(s)
Acne Mask
Other Intervention Name(s)
Light-Therapy Acne Device
Intervention Description
The light therapy device contains a combination of red and blue light-emitting diodes. The device is applied once daily, in the evening for a duration of 10 minutes
Intervention Type
Drug
Intervention Name(s)
2.5% Benzoyl Peroxide Treatment
Other Intervention Name(s)
BPO
Intervention Description
The BPO treatment is applied twice daily, once in the morning and once in the evening
Primary Outcome Measure Information:
Title
Percent Change of Global Face Total Acne Lesion Count From Baseline
Time Frame
Baseline to 12 Weeks
Secondary Outcome Measure Information:
Title
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 1
Time Frame
Baseline to 1 Week
Title
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 2
Time Frame
Baseline to 2 Weeks
Title
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 4
Time Frame
Baseline to 4 Weeks
Title
Percent Change of Global Face Total Acne Lesion Count From Baseline to Week 8
Time Frame
Baseline to 8 Weeks
Title
Acne Lesion Counts Total Global Face - Baseline
Description
Acne Lesion Count Total Global Face at Baseline
Time Frame
Baseline
Title
Acne Lesion Counts Total Global Face - Week 1
Description
Acne Lesion Count Total Global Face Week 1
Time Frame
1 Week
Title
Acne Lesion Counts Total Global Face - Week 2
Description
Acne Lesion Count Total Global Face Week 2
Time Frame
2 Weeks
Title
Acne Lesion Counts Total Global Face - Week 4
Description
Acne Lesion Count Total Global Face Week 4
Time Frame
4 Weeks
Title
Acne Lesion Counts Total Global Face - Week 8
Description
Acne Lesion Count Total Global Face Week 8
Time Frame
8 Weeks
Title
Acne Lesion Counts Total Global Face - Week 12
Description
Acne Lesion Count Total Global Face Week 12
Time Frame
12 Weeks
Title
Investigator Global Acne Assessment - Baseline
Description
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Time Frame
Baseline
Title
Investigator Global Acne Assessment - Week 1
Description
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Time Frame
1 Week
Title
Investigator Global Acne Assessment - Week 2
Description
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Time Frame
2 Weeks
Title
Investigator Global Acne Assessment - Week 4
Description
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Time Frame
4 Weeks
Title
Investigator Global Acne Assessment - Week 8
Description
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Time Frame
8 Weeks
Title
Investigator Global Acne Assessment - Week 12
Description
Investigator's assessment of subject's acne condition using a score of 0 (best) and 5 (worst) on the Modified Cook's scale. 0 Clear Residual hyperpigmentation and erythema may be present. Almost Clear. A few scattered comedones and a few (less than five) small papules. Mild.Easily recognizable; less than half the face is involved. Many comedones and many papules and pustules. Moderate More than half of the face is involved. Numerous comedones, papules and pustules. Severe. Entire face is involved. Covered with comedones, numerous papules and pustules and few nodules and cysts. Very Severe.Highly inflammatory acne covering the face; with nodules and cysts present.
Time Frame
12 Weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Has mild to moderate acne Has 10 - 100 pimples, 10 - 50 inflamed red pimples, up to 2 raised bumps and no cysts In general good health Must avoid excessive sun exposure and any light treatments or any professional or aesthetic spa-like procedures Must not be pregnant, nursing or intend to become pregnant during the study Must agree to practice a medically acceptable form of birth control. Must be able to read, speak, write and understand English Exclusion Criteria: Allergies or sensitivities to product ingredients or to light Has severe acne or pre-existing dermatological facial condition Has an uncontrolled disease or immune deficient disorder Is pregnant, breast-feeding or intending to become pregnant Has been taking prescription drug medication for acne or antibiotics for the past 6 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alicia D Bucko, D.O.
Organizational Affiliation
Academic Dermatology Associates
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lily Jiang, Ph.D.
Organizational Affiliation
Thomas J. Stephens and Associates, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Academic Dermatology Associates
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87106
Country
United States
Facility Name
Thomas J. Stephens and Associates, Inc.
City
Richardson
State/Province
Texas
ZIP/Postal Code
75081
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
12589953
Citation
Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol. 2003 Jan 21;35(1):17-24. doi: 10.1111/j.1574-695X.2003.tb00644.x.
Results Reference
background
PubMed Identifier
6730638
Citation
Kjeldstad B. Photoinactivation of Propionibacterium acnes by near-ultraviolet light. Z Naturforsch C Biosci. 1984 Mar-Apr;39(3-4):300-2. doi: 10.1515/znc-1984-3-417.
Results Reference
background
PubMed Identifier
19150294
Citation
Barolet D. Light-emitting diodes (LEDs) in dermatology. Semin Cutan Med Surg. 2008 Dec;27(4):227-38. doi: 10.1016/j.sder.2008.08.003.
Results Reference
background

Learn more about this trial

A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.

We'll reach out to this number within 24 hrs